持続血糖測定器(CGM)のアジア市場

◆英語タイトル:ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEM MARKET FORECAST 2017-2025
◆商品コード:INKW704117
◆発行会社(調査会社):Inkwood Research
◆発行日:2017年4月1日
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アジア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD1,950 ⇒換算¥220,350見積依頼/購入/質問フォーム
Multi LicenseUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートでは、持続血糖測定器(CGM)のアジア市場について調査・分析し、持続血糖測定器(CGM)のアジア市場動向、市場予測、セグメント別分析、市場規模、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

KEYFINDINGSThe APAC CGMS market was valued at $40 million in the year 2016 and is expected to reach a value of $1339.25 million by 2025 with a CAGR of 48.7%. The Asia-Pacific CGMS market is anticipated to report the highest growth during the forecast period. An increase in awareness, high budget, and rise in the number of chronic diseases and the accelerating investment in healthcare infrastructure by the government are expected to be the market drivers for the growth of continuous glucose monitoring system market. The high acceleration in obesity cases and awareness and knowledge of disease management will lead to market growth on a global level.
The global CGMS market is anticipated to expand during the forecast years 2017-2025. The diverse factors leading to the CGMS market are an augmented increase in the number of people suffering from diabetes, authorization of artificial pancreas, greater awareness, and improved healthcare infrastructure and ease of using CGMS devices.
Continuous glucose monitoring system aids in measuring the content of sugar in blood in both hypoglycemic and hyperglycemic diabetic patients. It also implicates measuring glucose levels at regular intervals to get an exceptional insight into the glucose level trends. A glucose sensor is placed under the tissue as an injection with a syringe to get the glucose content from the tissue fluid. The glucose level data is then transmitted from the sensor to receiver display with the help of radio waves. Information of HbA1C and the levels of Fructosamine levels in the blood are also provided by the monitor.
On the global level, the number of diabetics has been accelerating at a startling rate. Currently, approximately 423 million people have diabetes and the statistics are anticipated to expand and reach up to 642 million people by 2030 according to the estimation of WHO data. The prevalence of diabetes is exceeding in the moderate to low income countries. Approximately 12.50% of the global health expenditure is spent on diabetes each year. The technological advancements and innovations as well as the authorization of the artificial pancreas benefit in the control and management of diabetes.
The market is segmented by application, product type, and geography. There are diverse product types comprising CGMS including the transmitters and receivers, and the sensors. The Sensors are further segmented on the basis of holter type retrospective sensors, insulin pumps, non-invasive glucose sensors, minimally invasive glucose sensors and real-time sensors. The glucose monitors applications end-users include homes, hospitals, diagnostics and clinics.

MARKET INSIGHTS
High acceleration in the prevalence of diabetes, rising health awareness in developing countries, changes in lifestyle, sedentary lifestyle, the rise in the need of efficient and hassle-free monitoring of blood and the launch of an artificial pancreas are the market drivers for CGMS.
The most market share includes the product type, transmitters, and receivers. During the forecast period, it is anticipated that the insulin pumps will show a good CAGR by capturing a big market share. An effective growth rate for Sensors is also expected during the forecast period.
Hospitals have the largest market share in terms of the end-user segment. The highest CAGR is expected for Home healthcare as an end-user.
High costing of continuous glucose monitoring systems, deficient reimbursement options, and stringent regulatory norms are the factors that are likely to restrain the market growth.

【レポートの目次】

1. RESEARCH SCOPE
1.1 STUDY GOALS
1.2 SCOPE OF THE STUDY MARKET AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1 SOURCES OF DATA
2.2 BOTTOM-UP APPROACH
2.3 TOP DOWN APPROACH
2.4 DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1 MARKET SUMMARY & KEY FINDINGS OF THE STUDY
4. MARKET OVERVIEW
4.2 DRIVERS AND IMPACT
4.2.1 INCREASE IN DIABETIC POPULATION
4.2.2 INCREASE IN HEALTHCARE EXPENDITURE
4.2.3 INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
4.2.4 TECHNOLOGY INTEGRATION
4.3.5 INCREASING CGMS AFFORDABILITY
4.3.6 LOW PRICE OF TECHNOLOGY
4.3 RESTRAIN AND IMPACT
4.3.1 HINDERANCE FROM GOVERNMENT REGULATIONS
4.3.2 SMBG MANUFACTURERS RESTRAINING CGMS GROWTH
5. MARKET BY COMPONENT TYPE
5.1SENSORS
5.2 TRANSMITTERS AND RECEIVERS
5.3 INSULIN PUMP
6. MARKET BY APPLICATION
6.1DIAGNOSTICS AND CLINICS
6.2 HOSPITALS
6.3 HOME SETTINGS
7 KEY ANALYTICAL
7.1 5 FORCES ANALYSIS
7.1.1 THREAT OF NEW ENTRANT
7.1.2 THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
7.1.3 BARGAINING POWER OF BUYERS
7.1.4 BARGAINING POWER OF SUPPLIER
7.1.5 INTENSITY OF COMPETITIVE RIVALRY
7.2 TOP THREE MARKET TRENDS
7.2.1 INADEQUATE REIMBURSEMENT OPTIONS FOR CGM
7.2.2 LACK OF KNOWLEDGE
7.2.3 REDUCTION OF HANDLING EFFORTS
7.3 TOP THREE GEOGRAPHIES
7.4 MERGER AND ACQUISITIONS
8. REGIONAL ANALYSIS
8.1 ASIA-PACIFIC (APAC)
8.1.1 CHINA
8.1.2 INDIA
8.1.3 AUSTRALIA
8.1.4 REST OF ASIA-PACIFIC (RoAP)
9. COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 MEDTRONIC
9.2.1 BUSINESS PROFILE
9.2.2 PRODUCT PORTFOLIO
9.2.3 REVENUE ANALYSIS
9.2.4 STRATEGIC INPUTS
9.2. 5 SCOT ANALYSIS
9.3 DEXCOM
9.3.1 BUSINESS PROFILE
9.3.2 PRODUCT PORTFOLIO
9.3.3 REVENUE ANALYSIS
9.3.4 STRATEGIC INPUTS
9.3.5 SCOT ANALYSIS
9.4 ABBOTT
9.4.1 BUSINESS PROFILE
9.4.2 PRODUCT PORTFOLIO
9.4.3 REVENUE ANALYSIS
9.4.4 STRATEGIC INPUTS
9.4.3 SCOT ANALYSIS
9.5 JOHNSON and JOHNSON
9.5.1 BUSINESS PROFILE
9.5.2 PRODUCT PORTFOLIO
9.5.3 REVENUE ANALYSIS
9.5.4 STRATEGIC INPUTS
9.5.5 SCOT ANALYSIS
9.6 INSULET CORP
9.6.1 BUSINESS PROFILE
9.6.2 PRODUCT PORTFOLIO
9.6.3 REVENUE ANALYSIS
9.6.4 SCOT ANALYSIS
9.7 TANDEM DIABETES
9.7.1 BUSINESS PROFILE
9.7.2 REVENUE ANALYSIS
9.7.3 PRODUCT PORTFOLIO
9.7.4 STRATEGIC INPUTS
9.7.5 SCOT ANALYSIS
9.8 ECHO THERAPEUTICS
9.8.1 BUSINESS PROFILE
9.8.2 REVENUE ANALYSIS
9.9 ROCHE DIAGNOSTICS
9.9.1 BUSINESS PROFILE
9.9.2 PRODUCT PORTFOLIO
9.9.3 REVENUE ANALYSIS
9.9.4 STRATEGIC INPUTS
9.9.5 SCOT ANALYSIS
9.10 NEMAURA MEDICAL INC.
9.10.1 BUSINESS PROFILE
9.10.2 PRODUCT PORTFOLIO
9.10.3 REVENUE ANALYSIS
9.10.4 STRATEGIC INPUTS
9.10.5 SCOT ANALYSIS
9.11 SENSEONICS
9.11.1 BUSINESS PROFILE
9.11.2 PRODUCT PORTFOLIO
9.11.3 REVENUE ANALYSIS
9.11.4 STRATEGIC INPUTS
9.11.5 SCOT ANALYSIS
9.12 GLYSENS INCORPORATED
9.12.1 BUSINESS PROFILE
9.12.2 PRODUCT PORTFOLIO
9.12.3 STRATEGIC INPUTS
9.12. 5 SCOT ANALYSIS

LIST OF TABLES
TABLE# 1 APAC CGMS MARKET BY GEOGRAPHY, 2017-2025 ($MILLION)
TABLE# 2 APAC CGMS MARKET, BY DEVICE TYPE, 2017-2025 ($MILLION)
TABLE# 3 APAC SENSORS MARKET, 2017-2025 ($MILLION)
TABLE# 4 APAC TRANSMITTERS AND RECEIVERS MARKET, 2017-2025 ($MILLION)
TABLE# 5 APAC INSULIN PUMP MARKET, 2017-2025 ($MILLION)
TABLE# 6 APACCGMS MARKET, BY APPLICATION (2015 – 2023)
TABLE# 7 APAC CGMS MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)

LIST OF FIGURES
FIGURE# 1 APAC CGMS MARKET SHARE, BY PRODUCT TYPE (2015)
FIGURE# 2 SENSORS MARKET, 2017-2025 ($MILLION)
FIGURE# 3 APAC TRANSMITTERS AND RECEIVERS MARKET, 2017-2025 ($MILLION)
FIGURE# 4 APAC INSULIN PUMPMARKET, 2017-2025 ($MILLION)
FIGURE# 5 APAC CGMS SHARE, BY APPLICATION (2016)
FIGURE# 6 APAC DIAGNOSTICS AND CLINICAL MARKET, 2017-2025 ($MILLION)
FIGURE# 7 APAC HOSPITALS MARKET, 2017-2025 ($MILLION)
FIGURE# 8 APAC HOME SETTING MARKET, 2017-2025 ($MILLION)
FIGURE# 9 TOP THREE GEOGRAPHIES 2015
FIGURE# 10 ASIA PACIFIC CGMS MARKET SHARE, BY COUNTRY (2015)
FIGURE# 11 CHINA CGMS MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE# 12 INDIA CGMS MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE# 13 AUSTRALIA CGMS MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE# 14ROAPAC CGMS MARKET REVENUE, 2017-2025 (IN USD MILLION)



★調査レポート[持続血糖測定器(CGM)のアジア市場] (コード:INKW704117)販売に関する免責事項を必ずご確認ください。
★調査レポート[持続血糖測定器(CGM)のアジア市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆